176 related articles for article (PubMed ID: 26748789)
1. Designing anti-diabetic β-cells microcapsules using polystyrenic sulfonate, polyallylamine, and a tertiary bile acid: Morphology, bioenergetics, and cytokine analysis.
Mooranian A; Negrulj R; Al-Salami H; Morahan G; Jamieson E
Biotechnol Prog; 2016 Mar; 32(2):501-9. PubMed ID: 26748789
[TBL] [Abstract][Full Text] [Related]
2. The incorporation of water-soluble gel matrix into bile acid-based microcapsules for the delivery of viable β-cells of the pancreas, in diabetes treatment: biocompatibility and functionality studies.
Mooranian A; Negrulj R; Al-Salami H
Drug Deliv Transl Res; 2016 Feb; 6(1):17-23. PubMed ID: 26671765
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Ionic Gelation- Vibrational Jet Flow Technique in Fabrication of Microcapsules Incorporating β-cell: Applications in Diabetes.
Mooranian A; Negrulj R; Al-Salami H
Curr Diabetes Rev; 2017; 13(1):91-96. PubMed ID: 26710877
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic β-cells.
Mooranian A; Negrulj R; Arfuso F; Al-Salami H
Artif Cells Nanomed Biotechnol; 2016; 44(1):194-200. PubMed ID: 25014218
[TBL] [Abstract][Full Text] [Related]
5. The Influence of Stabilized Deconjugated Ursodeoxycholic Acid on Polymer-Hydrogel System of Transplantable NIT-1 Cells.
Mooranian A; Negrulj R; Al-Salami H
Pharm Res; 2016 May; 33(5):1182-90. PubMed ID: 26818840
[TBL] [Abstract][Full Text] [Related]
6. Morphological, Stability, and Hypoglycemic Effects of New Gliclazide-Bile Acid Microcapsules for Type 1 Diabetes Treatment: the Microencapsulation of Anti-diabetics Using a Microcapsule-Stabilizing Bile Acid.
Mathavan S; Chen-Tan N; Arfuso F; Al-Salami H
AAPS PharmSciTech; 2018 Oct; 19(7):3009-3018. PubMed ID: 30062539
[TBL] [Abstract][Full Text] [Related]
7. The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study.
Mooranian A; Negrulj R; Arfuso F; Al-Salami H
Drug Deliv Transl Res; 2015 Oct; 5(5):511-22. PubMed ID: 26242686
[TBL] [Abstract][Full Text] [Related]
8. Innovative Microcapsules for Pancreatic β-Cells Harvested from Mature Double-Transgenic Mice: Cell Imaging, Viability, Induced Glucose-Stimulated Insulin Measurements and Proinflammatory Cytokines Analysis.
Mooranian A; Tackechi R; Jamieson E; Morahan G; Al-Salami H
Pharm Res; 2017 Jun; 34(6):1217-1223. PubMed ID: 28289997
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes.
Mathavan S; Chen-Tan N; Arfuso F; Al-Salami H
Drug Deliv; 2016 Oct; 23(8):2869-2880. PubMed ID: 26610261
[TBL] [Abstract][Full Text] [Related]
10. Multicompartmental, multilayered probucol microcapsules for diabetes mellitus: Formulation characterization and effects on production of insulin and inflammation in a pancreatic β-cell line.
Mooranian A; Negrulj R; Arfuso F; Al-Salami H
Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1642-53. PubMed ID: 26377035
[TBL] [Abstract][Full Text] [Related]
11. Advanced bile acid-based multi-compartmental microencapsulated pancreatic β-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment.
Mooranian A; Negrulj R; Chen-Tan N; Fakhoury M; Arfuso F; Jones F; Al-Salami H
Artif Cells Nanomed Biotechnol; 2016; 44(2):588-95. PubMed ID: 25358121
[TBL] [Abstract][Full Text] [Related]
12. Electrokinetic potential-stabilization by bile acid-microencapsulating formulation of pancreatic β-cells cultured in high ratio poly-L-ornithine-gel hydrogel colloidal dispersion: applications in cell-biomaterials, tissue engineering and biotechnological applications.
Mooranian A; Negrulj R; Takechi R; Jamieson E; Morahan G; Al-Salami H
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1156-1162. PubMed ID: 28776395
[TBL] [Abstract][Full Text] [Related]
13. The effect of molecular weights of microencapsulating polymers on viability of mouse-cloned pancreatic β-cells: biomaterials, osmotic forces and potential applications in diabetes treatment.
Mooranian A; Takechi R; Jamieson E; Morahan G; Al-Salami H
Pharm Dev Technol; 2018 Feb; 23(2):145-150. PubMed ID: 28425308
[TBL] [Abstract][Full Text] [Related]
14. Flow vibration-doubled concentric system coupled with low ratio amine to produce bile acid-macrocapsules of β-cells.
Mooranian A; Negrulj R; Al-Salami H
Ther Deliv; 2016; 7(3):171-8. PubMed ID: 26893249
[TBL] [Abstract][Full Text] [Related]
15. Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study.
Mooranian A; Raj Wagle S; Kovacevic B; Takechi R; Mamo J; Lam V; Watts GF; Mikov M; Golocorbin-Kon S; Stojanovic G; Al-Sallami H; Al-Salami H
Sci Rep; 2020 Jan; 10(1):106. PubMed ID: 31919411
[TBL] [Abstract][Full Text] [Related]
16. New Biotechnological Microencapsulating Methodology Utilizing Individualized Gradient-Screened Jet Laminar Flow Techniques for Pancreatic β-Cell Delivery: Bile Acids Support Cell Energy-Generating Mechanisms.
Mooranian A; Negrulj R; Takechi R; Jamieson E; Morahan G; Al-Salami H
Mol Pharm; 2017 Aug; 14(8):2711-2718. PubMed ID: 28682620
[TBL] [Abstract][Full Text] [Related]
17. The impact of allylamine-bile acid combinations on cell delivery microcapsules in diabetes.
Mooranian A; Negrulj R; Al-Salami H
J Microencapsul; 2016 Sep; 33(6):569-574. PubMed ID: 27574968
[TBL] [Abstract][Full Text] [Related]
18. The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects.
Mooranian A; Negrulj R; Takechi R; Mamo J; Al-Sallami H; Al-Salami H
Drug Deliv Transl Res; 2018 Jun; 8(3):543-551. PubMed ID: 29313296
[TBL] [Abstract][Full Text] [Related]
19. Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes.
Negrulj R; Mooranian A; Chen-Tan N; Al-Sallami HS; Mikov M; Golocorbin-Kon S; Fakhoury M; Watts GF; Arfuso F; Al-Salami H
Artif Cells Nanomed Biotechnol; 2016 Aug; 44(5):1290-7. PubMed ID: 25811999
[TBL] [Abstract][Full Text] [Related]
20. Oral gavage of nano-encapsulated conjugated acrylic acid-bile acid formulation in type 1 diabetes altered pharmacological profile of bile acids, and improved glycaemia and suppressed inflammation.
Mooranian A; Zamani N; Ionescu CM; Takechi R; Luna G; Mikov M; Goločorbin-Kon S; Kovačević B; Al-Salami H
Pharmacol Rep; 2020 Apr; 72(2):368-378. PubMed ID: 32048259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
